DEUTSCHE BANK AG\ - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 53 filers reported holding DESIGN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,201
-98.8%
509
-96.8%
0.00%
Q2 2023$100,176
-30.2%
15,901
-36.0%
0.00%
Q1 2023$143,419
-21.6%
24,856
+39.3%
0.00%
Q4 2022$183,049
-20.4%
17,841
+29.7%
0.00%
Q3 2022$230,000
+2.7%
13,759
-14.1%
0.00%
Q2 2022$224,000
-6.3%
16,020
+8.3%
0.00%
Q1 2022$239,000
-34.3%
14,790
-13.1%
0.00%
Q4 2021$364,000
+208.5%
17,018
+112.3%
0.00%
Q3 2021$118,000
-25.8%
8,015
+0.2%
0.00%
Q2 2021$159,0008,0000.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 5,364,850$78,810,0003.20%
Logos Global Management LP 2,772,501$40,728,0002.94%
EcoR1 Capital, LLC 1,863,098$27,369,0000.95%
RA Capital Management 2,186,636$32,122,0000.44%
Vivo Capital, LLC 530,991$7,800,0000.35%
Avoro Capital Advisors LLC 1,468,318$21,570,0000.34%
Artal Group S.A. 400,000$5,876,0000.13%
Rock Springs Capital Management LP 334,050$4,907,0000.10%
Baker Brothers Advisors 1,436,636$21,104,0000.09%
Eventide Asset Management 400,000$5,876,0000.08%
View complete list of DESIGN THERAPEUTICS INC shareholders